期刊文献+

中老年人轻度认知功能改变特点及与血脂水平关系的临床研究 被引量:6

Clinical research of the level of serum lipid in the elderly with mild cognitive impairment patients and their correlation
原文传递
导出
摘要 目的探讨中老年人轻度认知功能损害(MCI)的特点及与血脂水平的关系。方法对80例MCI患者和91例对照组应用简易精神状态量表(MMSE)和蒙特利尔认知评估量表(MOCA)进行认知功能评分及血脂水平的测定。结果(1)在MMSE中,MCI组的回忆能力及总分明显低于对照组(P〈0.05);(2)在MOCA中,MCI组的视空间与执行功能、注意、语言、延迟回忆及总分明显低于对照组(P〈0.05);(3)在血脂测定中,MCI组的血清总胆固醇(TC)和低密度脂蛋白胆固醇(LDL—C)的水平明显高于对照组(P〈0.05)。结论中老年MCI患者存在多个领域的认知功能损害,同时采用MMSE及MOCA量表,可以更加准确快速地筛查出Alzheimer病的高危人群。血清TC和LDL—C的升高与MCI的发病有一定相关性,给予降脂治疗对MCI及AD的防治可能有一定作用。 Objective To study in the elderly with mild cognitive impairment(MCI) characteris- tics and the relationship between lipid levels. Methods The 80 patients with MCI and 91 people selected as control group were assessed with mini-mental state examination(MMSE) and montreal cognitive assess- ment (MOCA) and were examed lipid. Results ( 1 ) In the MMSE test, recall ability and total score of the MCI group was significantly lower than control group( P 〈 0.05 ). (2) In the MOCA test, visual spatial and executive function, attention,language, delayed recall and total scores of the MCI group were significantly lower than control group( P 〈 0.05 ). (3)Serum total cholesterol(TC) and low-density lipoprotein choles- terol(LDL) level of MCI group was significantly higher than the control gronp(P 〈 0.05). Conclusion Middle-aged patients with MCI have multiple areas of cognitive impairment, we will be able to detect high- risk groups in the AD quicker and accurately screening by using the MMSE and MOCA. Serum TC and LDL-C increased the incidence of MCI, given lipid-lowering therapy may have a role in the prevention and treatment of MCI and AD.
出处 《临床内科杂志》 CAS 2012年第11期750-752,共3页 Journal of Clinical Internal Medicine
关键词 轻度认知功能障碍 血脂 简易精神状态量表 蒙特利尔认知评估量表 Mild cognitive impairment Srum lipid Mini-Mental status examination Montreal cognitive assessment scale
  • 相关文献

参考文献20

  • 1Gouras GK. Dementia Encyclopedia of Neuroscience,2009:403-408.
  • 2Ringman JM, Medina LD, Rdnguez-Agudel Y, et ai. Current concepts of mild cognitive impairment and their applicability to persons at-risk for familial Alzheimer disease. Curt Alzheimer Res ,2009,6:341-346.
  • 3Petersen RC, Thomas RG, Grundman M, et al. Vitamin E and donepezil for the treatment of the treatment of mild cognitive impairment. N Engl J Med ,2005,352:2379-2388.
  • 4Kate V, Allen R, Braim N, et al. The relationship between rype 2 diabe- tes And cognitive dysfunction : longitudinal studies and their methodo- logical Limitations. Neuroscience Bio behavioral Reviews, 2004,65: 17-23.
  • 5Petersen RC. Mild cognitive impairment. Continuum Lifelong Learning Neuro1,2007,13 : 15-38.
  • 6, v Dik MG, Jonker C, Comijs HC, et al. Contribution of metabolic syn- drome components to cognition in older individuals. Diabetes care, 2007,30 : 2665 -2660.
  • 7朱红莲,潘志红,王根发.轻度认知功能障碍患者血脂代谢的变化[J].上海交通大学学报(医学版),2008,28(5):516-517. 被引量:20
  • 8Tang BL, Kumar R. Biomarkers of mild cognitive impairment and Alzhe- imer disease. Ann Aead Med Singapore,2008,37:406-410.
  • 9Leow AD, Yanovsky I, Parikshak N, et al. Alzheimer disease, neuroim- aging initiative : a one-year follow up study using tens or based mor- phometry correlating degenerative rates, biomarkers and cognition. Neu- roimag,2009,45 : 645-655.
  • 10] Hansson O, Zetterberg H, Buchhave P, et al. Association between CSF biomarkers and incipient Alzheimer s disesase in patients with mild cog- nitive impairment : follow-up study. Lancet Neurol,2006 ,5 :228-234.

二级参考文献58

共引文献126

同被引文献62

  • 1滕香宇,刘伟,张英.中心性肥胖正常糖调节人群中不同胰岛素敏感性者的代谢特征及脂联素水平[J].中华内分泌代谢杂志,2007,23(1):30-31. 被引量:10
  • 2Tervo S, Kivipelto M, H^nninen T, et al. Incidence and risk factorsfor mild cognitive impairment: a population-based three-year fol-low-up study of cognitively healthy elderly subjects [J]. DementGeriatr Cogn Disord, 2004, 17(3): 196-203.
  • 3Reitz C, Tang MX, Manly J, et al. Hypertension and tibe risk of mildcognitive impainnent [J]. Arch Neurol, 2007, 64(12): 1734-1740.
  • 4血管性认知功能损害的专家共识[J].中华内科杂志,2007,46(12):1052-1055. 被引量:261
  • 5Emre M, Ford PJ, Bilgi B,et al. Cognitive impairment and de- mentia in Parkinson's disease: Practical issues and management [J]. Mov Disord, 2014, 29(5): 663-672.
  • 6Dunn KM, Nelson MT. Neurovascular signaling in the brain and the pathological consequences of hypertension [J]. Am J Physiol Heart Circ Physiol, 2014, 306(1): H1 14.
  • 7Toth P,Tucsek Z, Sosnowska D, et al. Age-related autoreg- ulatory dysfunction and cerebromicrovascular injury in mice with angiotensin Ⅱ-induced hypertension [ J ]. Cereb Blood Flow Metab, 2013, 33(11): 1 732-1 742.
  • 8Kelley BJ, Petersen RC. Alzheimer's disease and mild cognitive im- pairment [ J ]. Neurologic clinics,2007,25 ( 3 ) :577 - 609.
  • 9Petersen RC. Mild cognitive impairment:transition between aging and Alzheimer's disease [ J ]. Nenrologia ( Barcelona, Spain ), 2000,15(3) :93 -101.
  • 10Petersen RC, Smith GE, Waring SC, et al. Mild eognitive impair- ment : clinical characterization and outcome [ J ]. Archives of neurol- ogy,1999,56(3) :303 -308.

引证文献6

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部